Showing results (741-750 of 2,229) with videos related to
Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|September 25, 2003
Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PETIris Verel, Gerard W M Visser, Otto C Boerman, et al.Cancer Biotherapy & Radiopharmaceuticals|April 2, 2003
Potent stimuli combined with lipopolysaccaride and IFNgamma may improve immunotherapy against HCC by increasing the maturation and subsequent immune response of the dendritic cellsYukio Iwashita, Shigeru Goto, Kouichirou Tahara, et al.Cancer Biotherapy & Radiopharmaceuticals|February 19, 2004
Pharmacokinetics in mice of four oligomer-conjugated polymers for amplification targetingJiang He, Guozheng Liu, Surong Zhang, et al.Cancer Biotherapy & Radiopharmaceuticals|September 5, 2003
Chemotherapy tolerance after radioimmunotherapy with 90Y-CC49 monoclonal antibody in patients with advanced non-small cell lung cancer: clinical effects and hematologic toxicityFrancisco Robert, Elizabeth M Busby, Albert F LoBuglioCancer Biotherapy & Radiopharmaceuticals|September 5, 2003
Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT)Barbara H Biela, Leslie A Khawli, Peisheng Hu, et al.Cancer Biotherapy & Radiopharmaceuticals|September 5, 2003
Internal radionuclide dosimetry: diagnostic and therapeutic nuclear medicine, occupational and environmental exposures. Differences and similaritiesSören Mattsson, Lars Jacobsson, Lennart JohanssonCancer Biotherapy & Radiopharmaceuticals|September 25, 2003
Recent developments and future directions in the treatment of multiple myelomaDiely Pichardo, Seema Singhal, Jayesh Mehta, et al.Cancer Biotherapy & Radiopharmaceuticals|September 25, 2003
Early effects of low dose-rate radiation on cultured tumor cellsJörgen Carlsson, Emma Håkansson, Veronika Eriksson, et al.Cancer Biotherapy & Radiopharmaceuticals|November 25, 2003
Therapy with 188Re-labeled radiopharmaceuticals: an overview of promising results from initial clinical trialsJae Min Jeong, June-Key ChungCancer Biotherapy & Radiopharmaceuticals|November 25, 2003
Treatment of human solid malignancies with autologous activated lymphocytes and cimetidine: a phase II trial of the cancer biotherapy research groupRobert O Dillman, Gamini Soori, Carol DePriest, et al.Pageof 223